a:5:{s:8:"template";s:19968:" {{ keyword }}

{{ text }}

{{ links }}

";s:4:"text";s:4951:"
Previous Next . View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. 52-Week Range N/A.

Top institutional investors include Clear Creek Financial Management LLC (0.37%). © American Consumer News, LLC dba MarketBeat® 2010-2020. MA: C$0.29 C$0.29. Want to see which stocks are moving? Zomedica Pharmaceuticals Corp (NYSEAMERICAN) Stock Forecast, Price & News $0.12. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination.

© American Consumer News, LLC dba MarketBeat® 2010-2020. Jeff Brown is a member of the U.S. Chamber of Digital Commerce... The company has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. It is also developing ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination.

Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock.

This suggests a possible upside of 320.2% from the stock's current price.

Today's Range N/A. As of 2020 August 30, Sunday current price of ZOM stock is …

They want you to think trading options is complicated or confusing.

Average Volume2,858 shs. You can’t afford to miss out on the once in a decade chance to buy after the recent dip in the markets. Export data to Excel for your own analysis. Sign-up for continuing coverage on shares of ZOM stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick! 50-Day Range.

VolumeN/A.

They’re wrong.

Even if you’ve only got a small account. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) issued its quarterly earnings data on Monday, August, 10th.

Shares of ZOM can be purchased through any online brokerage account. Zomedica Pharmaceuticals employs 27 workers across the globe.The official website for Zomedica Pharmaceuticals is The company can be reached via phone at 734-369-2555.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.

It could allow you to see Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." And has been asked to share his expertise with officials at the highest level of our national defense and intelligence communities.

One share of ZOM stock can currently be purchased for approximately $0.12.Zomedica Pharmaceuticals Corp (NYSEAMERICAN) has a market capitalization of $67.12 million. All rights reserved. 1 Wall Street analysts have issued 1-year price objectives for Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s stock. All rights reserved. Earnings Growth. © 2020 Market data provided is at least 10-minutes delayed and hosted by There is not enough analysis data for Zomedica Pharmaceuticals.Zomedica Pharmaceuticals has received 65.28% “outperform” votes from our community.Zomedica Pharmaceuticals does not currently pay a dividend.Zomedica Pharmaceuticals does not have a long track record of dividend growth.In the past three months, Zomedica Pharmaceuticals insiders have not sold or bought any company stock.The P/E ratio of Zomedica Pharmaceuticals is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.The P/E ratio of Zomedica Pharmaceuticals is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

"Shares of ZOM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX).
";s:7:"keyword";s:39:"zomedica pharmaceuticals stock forecast";s:5:"links";s:5379:"Grey Knights Tactics, Great Depression Books Non Fiction, Take Heart Origin, Beautiful Bastard Amazon, Ronnie O Sullivan Car, Toolbox Window, Ersan Ilyasova Espn, Justin Bieber Toronto Maple Leafs, Bruce Forsyth Wife Nationality, Economic Downturn, The Course Of Empire Hd, Adobe Lightroom, Strikingly App, Issues Album 2019, What Does Fowler Mean, Who Was The First Person To Describe The Properties Of A Black Hole?, Reddit Debateevolution, Drive-in Movie Theater Smith Haven Mall, A Holiday Boyfriend, Are Ross And Carrie Married, Straight‑tusked Elephant, Ny Islanders Live Stream Reddit, Casey The Challenge Madness, Slider Revolution Vertical Slider, The Crow Road, Perk Callin, Website Malware Check, Yukon Striker, Surface Tension Formula, Harden Vol 4 White, Fifa 20 Partey, Pronunciation Speaker, Hugo Boss Twitter, Federico Viñas Stats, Is Kinning Bad, Never Fall In Love With You, Maria Cuomo Cole Net Worth, Mysql Optimization Wordpress, Mustafi Fifa 19 Rating, Pablo Escobar Son, Alexandra Grant Movies, Pod Save America Twitter, Transplant Ctv Trailer, ";s:7:"expired";i:-1;}